神経血管インターベンションデバイスの世界市場：製品、プロセス、症状、最終用途別 - 予測（2024年～2030年）

世界の神経血管インターベンションデバイスの市場規模は、2023年に40億1,000万米ドルとなり、2024年には42億5,000万米ドルに達し、CAGR6.46％で2030年には62億1,000万米ドルに達すると予測されています。

神経血管インターベンションデバイスは、脳や神経系の血管に影響を及ぼす神経血管障害の治療用に設計された先進医療機器です。これらの医療機器は、動脈瘤、動静脈奇形（AVM）、虚血性脳卒中などの疾患に対する低侵襲処置を可能にします。ステント、塞栓コイル、フローダイバータ、マイクロカテーテル、血栓回収装置などがあります。神経血管疾患の複雑な性質と神経系の重要な機能のため、これらの器具の使用には高い精度と熟練したインターベンショナル神経科医が必要です。脳卒中、動脈瘤、狭窄を含む神経血管疾患の有病率の増加が、神経血管インターベンションデバイスの必要性を高めています。在院日数の短縮、回復時間の短縮、合併症のリスクの低下などの利点から、従来の手術よりも低侵襲手術への傾斜が高まっています。神経血管インターベンションの成功は、熟練した専門家と高度なヘルスケアインフラの有無に大きく依存しますが、地域によってはそれが不足している場合もあります。神経血管インターベンションには高い精度と技術が要求されます。しかし、複雑な血管構造におけるナビゲーションの困難さなど、機器の設計や性能における技術的な限界は、手術の合併症につながる可能性があります。主な企業は、より高度で信頼性が高く、安全な神経血管インターベンションデバイスの創出を目指し、現在進行中の研究開発に取り組んでいます。これには、ナビゲーション能力の向上、血栓除去の有効性、血管の治癒を早める装置などが含まれます。神経血管インターベンションにおけるAIとロボティクスの統合は、精度を高め、手術時間を短縮し、患者の転帰を改善する可能性があります。

地域別洞察

米国とカナダを中心とする南北アメリカは、高度なヘルスケアインフラ、高い患者意識、研究開発への多額の投資により、神経血管インターベンションデバイスが高度に発展している地域です。この地域の顧客は、迅速な回復が可能な革新的で低侵襲なソリューションを求めており、有効性と安全性が証明された製品を強く求めています。米国における最近の特許は、機器の精度を高め、手技による合併症を減らすことに重点を置いています。カナダの国民皆保険制度は、機器の承認プロセスは厳しいものの、こうした治療への患者のアクセスをサポートしています。アジア太平洋の神経血管インターベンションデバイス市場は、ヘルスケア支出の増加により急速に拡大しています。高齢化社会の中で神経疾患の有病率が高まっていることも、神経血管インターベンションデバイスの採用を後押ししています。現地メーカーは研究開発に多額の投資を行い、国際ブランドとの競争に挑んでいます。日本は高いヘルスケア支出と技術的洗練性によりアジア太平洋の主要な貢献国であり、患者は臨床的エビデンスに裏打ちされたイノベーションを強く望んでいます。インド市場は、医療意識の高まりとヘルスケアインフラの改善により、神経血管治療へのニーズが高まっているのが特徴です。EUの患者は一般に、高品質で耐久性のある神経血管器具を求めています。最近のEUのイニシアチブは、機器承認プロセスを合理化するための規制要件の調和に重点を置いており、メーカーと患者に利益をもたらしています。医療機器の性能、有効性、安全性、製造に関する厳しい規制は、神経血管インターベンションデバイスの進展と採用のための標準化された枠組みを作り出しています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは、神経血管インターベンションデバイス市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、事業戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront（F）、Pathfinder（P）、Niche（N）、Vital（V）に分類されます。

市場シェア分析

市場シェア分析は、神経血管インターベンションデバイス市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界市場で確固たる足場を築こうとする組織にとって不可欠です。企業は、神経血管インターベンションデバイス市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で神経血管疾患の発生率が増加
    • 低侵襲手術への関心が高まる
  • 抑制要因
    • 神経血管インターベンションデバイスの償還シナリオの不足と製品リコール
  • 機会
    • 神経血管インターベンションデバイスにおける技術的進歩
    • 神経血管研究開発・治療センターへの投資増加
  • 課題
    • 神経血管インターベンションデバイスの操作に関する技術的制限
• 市場セグメンテーション分析
  • 製品：さまざまな種類の血管内神経外科手術におけるカテーテルの基本的な役割
  • プロセス：脳血管造影における神経血管インターベンションデバイスの利用拡大
  • 症状：虚血性脳卒中に対する神経血管インターベンションデバイスの利用急増
  • 最終用途：病院の総合的な設備と専門スタッフが神経血管インターベンションデバイスの導入を拡大
• 市場動向分析
  • 南北アメリカにおける神経血管ヘルスケアインフラの進歩と確立されたインターベンションデバイスプロバイダーの存在
  • 技術革新と堅牢なヘルスケアインフラが、アジア太平洋で神経血管インターベンションデバイスの使用を促進
  • 欧州・中東・アフリカの規制当局による神経血管インターベンションデバイスの承認が増加
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析

第6章 神経血管インターベンションデバイス市場：製品別

• バルーンシステム
• 頸動脈ステント
• カテーテル
• 塞栓コイル
• 塞栓保護デバイス
• フローダイバータ
• ガイドワイヤー
• 頭蓋内ステント
• 嚢内デバイス
• 神経血栓除去装置

第7章 神経血管インターベンションデバイス市場：プロセス別

• 頸動脈内膜切除術
• 脳血管造影検査
• コイリング
• フローダイバージョン
• 顕微手術クリッピング
• 神経血栓除去術
• ステント

第8章 神経血管インターベンションデバイス市場：症状別

• 動静脈奇形
• 脳動脈瘤
• 虚血性脳卒中
• 狭窄症治療

第9章 神経血管インターベンションデバイス市場：最終用途別

• 外来手術センター
• 病院
• 専門クリニック

第10章 南北アメリカの神経血管インターベンションデバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の神経血管インターベンションデバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの神経血管インターベンションデバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析（2023年）
• FPNVポジショニングマトリックス（2023年）
• 競合シナリオ分析
  • ベイリスメディカルテクノロジーズ、静脈ステント再疎通を強化するPowerWire Pro RFガイドワイヤを発表
  • S3V Vascular Technologies、神経血管インターベンションのイノベーションのために30億ルピーの重要なシリーズBの資金調達を確保し、エリート投資家の関心を集めています。
  • ナノフレックス・ロボティクス、神経血管インターベンションのための革新的な遠隔操作システムを導入
  • Zylox-Tonbridge、Avingerと戦略的提携を結び、大中華圏における神経血管インターベンションの革新を推進
  • フィリップスが先進のAzurion Neuro Biplaneインターベンションシステムを発表
  • CEREGLIDE 71の紹介-CERENOVUSのTruCourseテクノロジーによる脳卒中インターベンションの画期的成果
  • オーバスネイチとアボットのCSIが米国での独占販売提携を2027年を通して拡大
  • センソームと旭インテック、AI搭載の先進的なClotild Smart Guidewireで提携
  • ストライカー、神経血管インターベンション分野での提供を拡大するため、Cerus Endovascularを買収
  • インフィニティニューロ、インスピラ吸引カテーテルのCEマークを取得

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. NEUROVASCULAR INTERVENTION DEVICES MARKET DYNAMICS
• FIGURE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID STENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID STENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRASACCULAR DEVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRASACCULAR DEVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ULTRASOUND-ASSISTED DEVICES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ULTRASOUND-ASSISTED DEVICES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ENDARTERECTOMY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ENDARTERECTOMY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COILING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COILING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROSURGICAL CLIPPING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROSURGICAL CLIPPING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANEURYSMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANEURYSMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENOSIS TREATMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENOSIS TREATMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 67. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 68. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 69. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 70. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 71. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 72. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 73. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 74. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 75. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 76. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 77. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 78. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 79. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 80. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 81. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 82. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 83. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 84. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 85. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 86. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 87. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 88. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 89. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 90. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 91. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 92. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 93. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 94. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 95. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 96. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 97. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 98. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 99. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 100. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 101. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 102. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 103. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 104. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 105. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 106. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 107. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 108. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 109. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 110. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 111. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 112. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 113. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 114. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 115. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 116. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 117. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 118. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 119. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 120. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 121. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 122. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 123. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 124. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 125. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 126. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 127. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 128. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 129. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 130. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 131. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 132. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 133. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 134. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 135. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 136. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 137. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 138. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 139. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 140. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 141. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 142. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 143. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 144. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 145. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 146. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 147. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 148. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 149. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 150. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 151. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 152. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 153. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 154. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 155. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 156. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 157. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 158. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 159. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 160. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 161. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 162. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 163. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 164. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 165. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 166. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 167. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 168. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 169. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 170. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 171. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 172. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 173. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 174. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 175. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 176. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 177. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 178. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 179. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 180. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 181. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 182. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 183. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 184. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 185. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 186. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 187. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 188. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 189. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 190. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 191. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 192. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 193. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 194. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 195. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 196. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 197. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 198. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 199. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 200. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 201. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 202. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 203. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 204. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 205. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 206. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 207. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 208. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 209. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 210. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 211. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 212. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 213. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 214. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 215. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 216. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 217. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 218. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 219. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 220. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 221. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 222. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 223. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 224. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 225. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 226. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 227. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 228. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 229. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 230. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 231. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 232. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 233. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 234. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 235. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 236. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 237. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 238. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 239. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 240. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 241. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 242. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 243. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 244. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 245. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 246. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 247. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 248. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 249. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 250. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 251. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 252. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 253. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 254. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 255. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 256. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 257. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 258. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 259. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 260. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 261. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 262. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 263. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 264. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 265. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 266. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 267. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 268. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 269. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 270. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 271. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 272. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 273. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 274. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 275. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 276. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 277. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 278. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 279. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 280. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 281. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 282. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 283. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 284. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 285. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 286. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 287. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 288. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 289. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 290. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 291. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
• TABLE 292. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
• TABLE 293. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
• TABLE 294. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
• TABLE 295. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 296. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATIO

[183 Pages Report] The Neurovascular Intervention Devices Market size was estimated at USD 4.01 billion in 2023 and expected to reach USD 4.25 billion in 2024, at a CAGR 6.46% to reach USD 6.21 billion by 2030.

Neurovascular intervention devices are advanced medical apparatuses designed for the treatment of neurovascular disorders that affect the blood vessels in the brain and the nervous system. These devices enable minimally invasive procedures for conditions such as aneurysms, arteriovenous malformations (AVMs), and ischemic strokes. They include stents, embolic coils, flow diverters, microcatheters, and clot retrieval devices. The application of these devices requires high precision and skilled interventional neurologists due to the complex nature of neurovascular diseases and the critical function of the nervous system. The rising prevalence of neurovascular conditions, including strokes, aneurysms, and stenosis, has driven the need for neurovascular intervention devices. There is a growing inclination toward minimally invasive surgeries over traditional surgeries due to benefits such as shorter hospital stays, reduced recovery time, and lower risk of complications. The successful implementation of neurovascular interventions is highly dependent on the availability of skilled professionals and advanced healthcare infrastructure, which can be lacking in some regions. Neurovascular interventions require high precision and skill. However, technical limitations in device design and performance, such as navigation difficulties in complex vascular structures, can lead to procedural complications. Key players are exploring ongoing research and development efforts aimed at creating more advanced, reliable, and safer neurovascular intervention devices. These include devices with improved navigability, effectiveness in clot removal, and devices that promote faster vessel healing. The integration of AI and robotics in neurovascular interventions can enhance precision, reduce procedure times, and potentially improve patient outcomes.

Regional Insights

The Americas region, particularly the U.S. and Canada, presents a highly developed landscape for neurovascular intervention devices due to its advanced healthcare infrastructure, high patient awareness, and significant investment in R&D. Customers here require innovative, minimally invasive solutions that offer quick recovery and have a strong preference for products with proven efficacy and safety. Recent patents in the U.S. have focused on enhancing device accuracy and reducing procedural complications. Canada's universal healthcare system supports patient access to these interventions, although the device approval process can be stringent. APAC's neurovascular intervention devices market is rapidly expanding, owing to its growing healthcare expenditure. The increased prevalence of neurological disorders among its aging population also necessitated the adoption of neurovascular intervention devices. Local manufacturers are investing heavily in R&D, striving to compete with international brands. Japan is a major contributor in the Asia-Pacific region due to its high healthcare spending and technological sophistication, and patients strongly prefer innovation backed by clinical evidence. The Indian market is characterized by a growing need for neurovascular treatments due to increasing healthcare awareness and improving healthcare infrastructure. EU patients generally seek high-quality, durable neurovascular devices. Recent EU initiatives have focused on harmonizing regulatory requirements to streamline device approval processes, benefitting manufacturers and patients. Stringent regulations pertaining to the performance, efficacy, safety, and manufacture of medical devices have created a standardized framework for the progress and adoption of neurovascular intervention devices.

Market Insights

• Market Dynamics

The market dynamics represent an ever-changing landscape of the Neurovascular Intervention Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

• Market Drivers
  • Increasing incidence of neurovascular diseases worldwide
  • Growing preference for minimally invasive procedures

• Market Restraints
  • Lack of reimbursement scenario and product recall for neurovascular intervention devices

• Market Opportunities
  • Technological advancements in neurovascular intervention devices
  • Rising investments in neurovascular R&D and treatment center

• Market Challenges
  • Technical limitations of operating neurovascular intervention devices
• Market Segmentation Analysis
  • Product: Fundamental role of catheters in various types of endovascular neurosurgical procedures
  • Process: Proliferating utilization of neurovascular intervention devices in cerebral angiography
  • Indication: Burgeoning utilization of neurovascular intervention devices for ischemic strokes
  • End-use: Comprehensive facilities and specialized personnel in hospitals expanding the adoption of neurovascular intervention devices

• Market Disruption Analysis
• Porter's Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Neurovascular Intervention Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Neurovascular Intervention Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Baylis Medical Technologies Introduces PowerWire Pro RF Guidewire for Enhanced Venous Stent Recanalization

Baylis Medical Technologies Inc., announced the 510(k) clearance and subsequent launch of its PowerWire Pro Radiofrequency (RF) Guidewire in the United States. Specifically engineered for venous stent recanalization in cases of complete occlusion, this innovative device utilizes radiofrequency technology to navigate through totally occluded peripheral vessel stents. [Published On: 2024-03-20]

S3V Vascular Technologies Secures Key Series B Funding of INR 300 Crore for Neurovascular Intervention Innovation, Attracting Elite Investor Interest

S3V Vascular Technologies secured a robust financial investment of INR 300 crore in Series B funding. The investment highlights a growing confidence in S3V Vascular Technologies' innovative approaches and product offerings in the neurovascular domain. This capital contributes to expanding the company's product line, enhancing its research and development capabilities, and broadening its market reach, particularly in the neurovascular intervention space. [Published On: 2024-03-15]

Nanoflex Robotics Deployed Revolutionary Remote-Operable System for Neurovascular Interventions

Nanoflex Robotics, a Switzerland-based innovator, deployed its remote-capable robotics system at the Jacobs Institute in Buffalo, USA, marking a significant advancement in neurovascular intervention technology. The system integrates a compact magnetic field generator with a navigation control unit, enabling physicians to precisely control, maneuver, and guide ultra-flexible devices through the intricate pathways of the body's vasculature. This breakthrough technology facilitates a wide array of complex vascular interventions by allowing direct manipulation of the guidewire's tip, dramatically enhancing the precision and safety of these procedures. [Published On: 2024-03-11]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Neurovascular Intervention Devices Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Intervention Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Asahi Intecc Co., Ltd., Balt Group, Boston Scientific Corporation, Carl Zeiss AG, Edwards Lifesciences Corporation, Evasc Medical Systems Corp., GE Healthcare, Imperative Care Inc., Integer Holdings Corporation, Japan Lifeline Co., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., LivaNova PLC, Medikit Co., Ltd., Medtronic PLC, Merit Medical Systems, Inc., Microport Scientific Corporation, Nanoflex Robotics AG, NeuroSafe Medical Co., Ltd., Penumbra, Inc., Phenox GmbH by Wallaby Medical, LLC, Rapid Medical Ltd., Route 92 Medical, Inc., Siemens Healthineers AG, Stryker Corporation, Terumo Corporation, and Zylox-Tonbridge Medical Technology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Neurovascular Intervention Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Balloon Systems
  • Carotid Stents
  • Catheters
  • Embolic Coils
  • Embolic Protection Devices
  • Flow Diverters
  • Guidewires
  • Intracranial Stents
  • Intrasaccular Devices
  • Neurothrombectomy Devices
    • Aspiration Devices
    • Stent Retrievers
    • Ultrasound-assisted Devices
• Process
  • Carotid Endarterectomy
  • Cerebral Angiography
  • Coiling
  • Flow Diversion
  • Microsurgical Clipping
  • Neurothrombectomy
  • Stenting

• Indication
  • Arteriovenous Malformations
  • Cerebral Aneurysms
  • Ischemic Strokes
  • Stenosis Treatment

• End-use
  • Ambulatory Surgical Centers
  • Hospitals
  • Speciality Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of neurovascular diseases worldwide
    • 5.1.1.2. Growing preference for minimally invasive procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of reimbursement scenario and product recall for neurovascular intervention devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in neurovascular intervention devices
    • 5.1.3.2. Rising investments in neurovascular R&D and treatment center
  • 5.1.4. Challenges
    • 5.1.4.1. Technical limitations of operating neurovascular intervention devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Fundamental role of catheters in various types of endovascular neurosurgical procedures
  • 5.2.2. Process: Proliferating utilization of neurovascular intervention devices in cerebral angiography
  • 5.2.3. Indication: Burgeoning utilization of neurovascular intervention devices for ischemic strokes
  • 5.2.4. End-use: Comprehensive facilities and specialized personnel in hospitals expanding the adoption of neurovascular intervention devices
• 5.3. Market Trend Analysis
  • 5.3.1. Advancing neurovascular healthcare infrastructure in the Americas and the presence of established intervention device providers
  • 5.3.2. Technological innovations and robust healthcare infrastructure driving use of neurovascular intervention devices in the APAC region
  • 5.3.3. Growing approvals for neurovascular intervention devices from regulatory authorities in the EMEA region
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework Analysis

6. Neurovascular Intervention Devices Market, by Product

• 6.1. Introduction
• 6.2. Balloon Systems
• 6.3. Carotid Stents
• 6.4. Catheters
• 6.5. Embolic Coils
• 6.6. Embolic Protection Devices
• 6.7. Flow Diverters
• 6.8. Guidewires
• 6.9. Intracranial Stents
• 6.10. Intrasaccular Devices
• 6.11. Neurothrombectomy Devices

7. Neurovascular Intervention Devices Market, by Process

• 7.1. Introduction
• 7.2. Carotid Endarterectomy
• 7.3. Cerebral Angiography
• 7.4. Coiling
• 7.5. Flow Diversion
• 7.6. Microsurgical Clipping
• 7.7. Neurothrombectomy
• 7.8. Stenting

8. Neurovascular Intervention Devices Market, by Indication

• 8.1. Introduction
• 8.2. Arteriovenous Malformations
• 8.3. Cerebral Aneurysms
• 8.4. Ischemic Strokes
• 8.5. Stenosis Treatment

9. Neurovascular Intervention Devices Market, by End-use

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Hospitals
• 9.4. Speciality Clinics

10. Americas Neurovascular Intervention Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Neurovascular Intervention Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Neurovascular Intervention Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Baylis Medical Technologies Introduces PowerWire Pro RF Guidewire for Enhanced Venous Stent Recanalization
  • 13.3.2. S3V Vascular Technologies Secures Key Series B Funding of INR 300 Crore for Neurovascular Intervention Innovation, Attracting Elite Investor Interest
  • 13.3.3. Nanoflex Robotics Deployed Revolutionary Remote-Operable System for Neurovascular Interventions
  • 13.3.4. Zylox-Tonbridge Forms Strategic Alliance with Avinger to Innovate Neurovascular Interventions in Greater China
  • 13.3.5. Philips Unveils Advanced Azurion Neuro Biplane Interventional System
  • 13.3.6. Introducing CEREGLIDE 71 a CERENOVUS's Breakthrough in Stroke Intervention with TruCourse Technology
  • 13.3.7. OrbusNeich and Abbott's CSI Extend Exclusive Distribution Partnership in the U.S. through 2027
  • 13.3.8. Sensome and Asahi Intecc Collaborate on Advanced AI-Powered Clotild Smart Guidewire
  • 13.3.9. Stryker's Acquired Cerus Endovascular to Expand its Offering in the Neurovascular Intervention Sector
  • 13.3.10. Infinity Neuro Secures CE Mark for Inspira Aspiration Catheters

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio